Deal Announcements

Euthymics Bioscience Garners $3 Million Venture Capital

Thursday, November 29, 2012 5:57:00 AM PDT | VentureDeal

   Cambridge, Massachusetts  --  Biotechnology company Euthymics Bioscience has landed $3 million in new venture capital equity financing, according to an SEC filing.

Euthymics is developing next generation treatments for depression for patients who do not respond adequately to existing SSRIs.

Investors in the financing were not disclosed.

Euthymics is still seeking $3 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1